Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Strip
Packaging
10*10
Price
₹199/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rosumore EZ 10 Tablet containing Rosuvastatin and Ezetimibe is used for the management of high cholesterol levels. It helps in lowering LDL cholesterol and improving overall lipid profile.
Rosuvastatin reduces cholesterol synthesis in the liver, while Ezetimibe decreases cholesterol absorption from the intestine. This dual action provides effective control over cholesterol levels and supports cardiovascular health.
The tablet is widely prescribed in cardiology practice for lipid management, especially in patients requiring combination therapy, leading to consistent demand and long-term usage.
With increasing cases of lifestyle disorders and cardiovascular diseases, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and strong clinical acceptance make it a reliable product for consistent sales and growth in the cardiac segment.
May cause headache, muscle pain, nausea, abdominal discomfort, or mild liver enzyme elevation. Rarely, serious muscle problems (myopathy or rhabdomyolysis) may occur.
Primary hypercholesterolemia Mixed dyslipidemia Familial hypercholesterolemia Prevention of cardiovascular disease in high-risk patients
Take under medical supervision, preferably once daily, with or without food. Regular liver function and lipid profile monitoring is advised. Inform your doctor about any muscle pain, weakness, or pre-existing liver/kidney conditions. Avoid excessive alcohol intake.
Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin (5mg) tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin 20 mg + fenofibrate 160 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rosuvastatin 10 mg + Ezetimibe 10 mg Tablet is a cardiovascular and anti-hyperlipidemic combination used for the management of high cholesterol, mixed dyslipidemia, and prevention of cardiovascular diseases such as heart attack and stroke. This combination works by reducing cholesterol production (Rosuvastatin) and decreasing cholesterol absorption (Ezetimibe), making it a widely prescribed cardiac care segment product by cardiologists and physicians.
Medical distributors and wholesalers benefit from the high and continuous demand in chronic cholesterol management therapy. Lipid-lowering medicines are used for long-term and often lifelong treatment, ensuring regular repeat prescriptions, stable monthly sales, and strong market demand in both retail and hospital segments.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiovascular and lipid-lowering segment, including Rosuvastatin + Ezetimibe combinations. We provide monopoly-based distribution rights, quality-assured manufacturing, and consistent supply support to help franchise partners build a strong presence in the chronic cardiac care market.
Wholesalers and stockists benefit from consistent prescription demand, strong cardiology usage, and long-term patient dependency. Since cholesterol management is a continuous therapy segment, it ensures steady product movement, low seasonal impact, and sustainable profit margins in pharmaceutical distribution.
Medical distributors, stockists, and pharma professionals interested in cardiovascular and lipid management products can contact Cafoli Lifecare for pricing, monopoly franchise rights, and availability details. We provide full support including product supply, marketing materials, and territory-wise business development assistance.